SCHEMBL2139497

SCHEMBL2139497

CCOC(Cc1cccc(OC)c1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 15/20 0.60
PPARG P37231 13/20 0.60
PPARD Q03181 4/20 0.54
TAAR1 Q96RJ0 2/20 0.53
FFAR1 O14842 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811237 1.00 PPARA (0.60) PPARAPPARGPPARDTAAR1FFAR1
SCHEMBL10909366 0.83 PPARG (0.54) PPARAPPARGTAAR1
SCHEMBL6055973 0.82 PPARA (0.73) PPARAPPARGPPARD
SCHEMBL4455247 0.82 PPARA (0.73) PPARAPPARGPPARD
SCHEMBL1670312 0.81 PPARA (0.69) PPARAPPARGPPARD
SCHEMBL4993002 0.81 PPARA (0.69) PPARAPPARGPPARD
SCHEMBL756254 0.81 PPARG (0.57) PPARAPPARGPPARD
SCHEMBL7617610 0.81 PPARA (0.72) PPARAPPARGPPARD
SCHEMBL6311891 0.80 TAAR1 (0.64) TAAR1FFAR1
SCHEMBL14332309 0.80 PPARA (0.58) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906669-B2 Metallocene-based phosphorus chiral phosphines SOLVIAS AG (CH) 2011-03-15 US disclosed
EP-1844061-B1 METALLOCENE-BASED PHOSPHORUS CHIRAL PHOSPHINES SOLVIAS AG (CH) 2010-08-04 EP disclosed
US-20090137824-A1 METALLOCENE-BASED PHOSPHORUS CHIRAL PHOSPHINES PHOENIX CHEMICALS LTD (GB) 2009-05-28 US disclosed
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids PHOENIX CHEMICALS LTD. (GB) 2008-10-02 US disclosed
EP-1844061-A1 METALLOCENE-BASED PHOSPHORUS CHIRAL PHOSPHINES Phoenix Chemicals Limited (GB) 2007-10-17 EP disclosed
EP-1838654-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS Phoenix Chemicals Limited (GB) 2007-10-03 EP disclosed
WO-2006075166-A1 METALLOCENE-BASED PHOSPHORUS CHIRAL PHOSPHINES PHOENIX CHEMICALS LTD. (GB) 2006-07-20 WO disclosed
WO-2006075177-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS PHOENIX CHEMICALS LTD. (GB) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137824-A1 METALLOCENE-BASED PHOSPHORUS CHIRAL PHOSPHINES POLL, ZNF207, ZC3HAV1L PPARA 164/4885PPARG 443/4885PPARD 505/4885
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids AS3MT, PPA1, AGPS PPARA 97/4885PPARG 521/4885PPARD 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.